Purpose: An update on pharmacotherapy for achieving and maintaining abstinence and mitigating hepatic damage in patients with alcoholic liver disease (ALD) is presented. Individual variation in the severity, presentation, and complex pathologenesis of ALD defines barriers to effective treatment. …

READ FULL ARTICLE Curated publisher From www.ajhp.org